PUBLISHER: The Business Research Company | PRODUCT CODE: 1889609
PUBLISHER: The Business Research Company | PRODUCT CODE: 1889609
Viral vector affinity resin is a specialized chromatography material created to selectively bind viral vectors based on specific surface proteins or capsid structures. It enables efficient purification of viral vectors from complex mixtures, removing impurities such as host cell proteins, DNA, and empty capsids, to produce high quality, high titer viral preparations for research or therapeutic use.
The main product types of viral vector affinity resin include adenoviral vector affinity resin, lentiviral vector affinity resin, adeno associated viral (AAV) vector affinity resin, retroviral vector affinity resin, and others. Adenoviral vector affinity resin is a specialized chromatography resin designed to selectively capture and purify adenovirus vectors based on their surface proteins or capsid structures. It is used in gene therapy, vaccine development, cell therapy, and other applications, serving end users such as pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The viral vector affinity resin market research report is one of a series of new reports from The Business Research Company that provides viral vector affinity resin market statistics, including viral vector affinity resin industry global market size, regional shares, competitors with a viral vector affinity resin market share, detailed viral vector affinity resin market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector affinity resin industry. This viral vector affinity resin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The viral vector affinity resin market size has grown rapidly in recent years. It will grow from $0.53 billion in 2024 to $0.62 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to rising adoption of gene therapies, increasing demand for vaccine development, growing investment in cell therapy research, expansion of biopharmaceutical manufacturing, and increasing focus on viral vector purification.
The viral vector affinity resin market size is expected to see rapid growth in the next few years. It will grow to $1.13 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to rising funding for advanced therapies, a growing number of viral vector clinical trials, increasing demand for high purity viral vectors, expansion of contract research organizations, and rising regulatory support for bioprocessing technologies. Major trends in the forecast period include technological advancements in affinity resin design, innovations in viral vector purification, developments in scalable bioprocessing, research and development in serotype specific resins, and the adoption of automated purification systems.
The increasing adoption of gene-based therapeutics is expected to drive the growth of the viral vector affinity resin market in the coming years. Gene-based therapeutics are advanced treatments that use DNA, RNA, or viral vectors to modify or regulate gene expression within a patient's cells. Adoption is rising due to improvements in delivery systems that enable safe, efficient, and targeted transport of genetic material into cells. Viral vector affinity resin supports the adoption of gene-based therapeutics by providing high-purity, scalable purification solutions, making them suitable for viral vector production. They reduce downstream processing challenges by effectively isolating viral vectors from impurities, improving production efficiency and supporting broader clinical and commercial applications. For instance, in December 2024, according to the American Society of Gene & Cell Therapy, a US based non-profit medical and scientific organization, the Food and Drug Administration approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the growing adoption of gene-based therapeutics is driving the expansion of the viral vector affinity resin market.
The rising healthcare expenditure is expected to propel the growth of the viral vector affinity resin market in the coming years. Healthcare expenditure refers to the total spending on medical services, treatments, facilities, research, and public health initiatives aimed at maintaining or improving health outcomes. Increasing expenditure is driven by the rising prevalence of chronic diseases, which require long-term and often costly treatments. Higher healthcare spending supports the viral vector affinity resin market by promoting investment in advanced biomanufacturing and purification technologies. Greater funding for gene and cell therapies increases demand for high-quality viral vector production, where affinity resins provide efficient purification, higher yields, and adherence to regulatory standards. For example, in May 2024, according to the Office for National Statistics, a UK based government department, total healthcare expenditure rose by 5.6 percent in nominal terms in 2023, reflecting 0.9 percent growth compared to 2022. Therefore, the increase in healthcare expenditure is driving the growth of the viral vector affinity resin market.
In July 2024, Repligen Corporation, a US based biotechnology company, acquired Tantti Laboratory Inc. for an undisclosed amount. Through this acquisition, Repligen aims to enhance viral vector affinity resin capabilities and strengthen high-throughput purification solutions for emerging modalities such as viral vectors and nucleic acids by integrating Tantti's advanced DuloCore bead technology with Avitide's AVIPure affinity ligands. Tantti Laboratory Inc. is a Taiwan based biomaterials engineering company specializing in chromatography resins capable of purifying viral vectors.
Major companies operating in the viral vector affinity resin market are Thermo Fisher Scientific, GE Healthcare Technologies Inc., Repligen Corporation, Creative Biolabs, JNC Corporation, Aptamer Group, ChromaGenix Inc.
North America was the largest region in the viral vector affinity resin market in 2024. The regions covered in viral vector affinity resin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the viral vector affinity resin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viral vector affinity resin market consists of sales of viral vector purification resins, pre-packed chromatography columns, ancillary purification kits, and consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Vector Affinity Resin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on viral vector affinity resin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for viral vector affinity resin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector affinity resin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.